Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Anger Expression, Self-focus and Coronary Heart Disease Risk Factors

This study has been completed.
Sponsor:
Information provided by:
National Heart, Lung, and Blood Institute (NHLBI)
ClinicalTrials.gov Identifier:
NCT00005244
First received: May 25, 2000
Last updated: March 15, 2016
Last verified: March 2005
  Purpose
To identify behavioral factors underlying the development of cardiovascular risk in young adults.

Condition
Cardiovascular Diseases
Heart Diseases
Coronary Disease

Study Type: Observational

Resource links provided by NLM:


Further study details as provided by National Heart, Lung, and Blood Institute (NHLBI):

Study Start Date: April 1989
Study Completion Date: March 1991
Detailed Description:

BACKGROUND:

The continued number of observations relating the Type A behavior pattern to coronary heart disease underscores the importance of developing a careful theoretical basis that may account for the virulent components of a coronary-prone personality.

CARDIA or Coronary Heart Disease Risk Development in Young Adults is a prospective, epidemiological study of coronary heart disease risk factors in cohorts of Black and white men and women, 18 to 30 years of age.

DESIGN NARRATIVE:

From each of the baseline tape-recorded Type A/B structured interviews administered in CARDIA, eighteen questions were scored for self-references, perceived pressure, anger experience, and anger expression. The anger measures were related to other measures of anger-in and hostility in order to establish their validity. The interrelationships of these factors were assessed separately for each of the socioeconomic status (SES) categories. A major focus of the analyses was to describe SES differences in how pressure was perceived and how anger was experienced and expressed. The study also assessed how these factors were related to data already collected on psychosocial risk factors and primary risk factors including blood pressure, serum cholesterol, and cigarette smoking.

The study completion date listed in this record was obtained from the "End Date" entered in the Protocol Registration and Results System (PRS) record.

  Eligibility

Ages Eligible for Study:   up to 100 Years   (Child, Adult, Senior)
Genders Eligible for Study:   Male
Accepts Healthy Volunteers:   No
Criteria
No eligibility criteria
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00005244

Sponsors and Collaborators
National Heart, Lung, and Blood Institute (NHLBI)
Investigators
OverallOfficial: Larry Scherwitz University of California at San Francisco
  More Information

ClinicalTrials.gov Identifier: NCT00005244     History of Changes
Other Study ID Numbers: 1125  R01HL041865 
Study First Received: May 25, 2000
Last Updated: March 15, 2016
Health Authority: United States: Federal Government

Additional relevant MeSH terms:
Cardiovascular Diseases
Heart Diseases
Coronary Disease
Coronary Artery Disease
Myocardial Ischemia
Vascular Diseases
Arteriosclerosis
Arterial Occlusive Diseases

ClinicalTrials.gov processed this record on December 09, 2016